Arca
Skip to content

HRH3: Histamine H3 receptor

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

The H3 subclass of histamine receptors could mediate the histamine signals in CNS and peripheral nervous system.

  • Drugs that act on it: 15
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it. 11 of 15 act as: Histamine H3 receptor antagonist; the rest name their own mechanism.
PitolisantApprovedHistamine H3 receptor inverse agonistInverse agonist—
ABT-288——Antagonist—
Bavisant——Antagonist—
Betahistine——Antagonist—
Cipralisant—Histamine H3 receptor agonistAgonist—
GSK-1004723——Antagonist—
GSK189254——Antagonist—
GSK239512——Antagonist—
Irdabisant——Antagonist—
JNJ-17216498——Antagonist—
JNJ-39220675——Antagonist—
MK-0249—Histamine H3 receptor inverse agonistInverse agonist—
PF-03654746——Antagonist—
PF-03654764——Antagonist—
SUVN-G3031—Histamine H3 receptor inverse agonistInverse agonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Obstructive sleep apnea syndrome
0.49
Narcolepsy-cataplexy syndrome
0.46
Cataplexy
0.38
Neurodegenerative disease
0.37
Vertigo
0.37
Hypersomnia
0.37
Idiopathic hypersomnia
0.32
Parkinson disease
0.28

Drugs and mechanisms are from ChEMBL CHEMBL264 (CC BY-SA 3.0). Gene name, function (UniProt Q9Y5N1, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.